Previous studies have demonstrated elevated circulating levels of PANcreatic DERived factor (PANDER) overexpression induced a selective hepatic insulin resistant phenotype in the liver of the PANDER transgenic mouse model. Here we utilized SILAC for "spike-in" as a quantitative mass spectrometry based proteomic workflow to reveal proteomic profile changes between the PANDER transgenic mouse and the wild-type mouse.